期刊文献+

胆道肿瘤基础研究进展与展望 被引量:2

The basic research progress and prospect on biliary tract cancer
原文传递
导出
摘要 胆管癌是一种来源于肝内或肝外胆管上皮的恶性肿瘤,是最具挑战和备受关注的胆道疾病.其发生的主要诱因尚无法明确,大多数学者认为是通过长期的表观遗传学改变的累积,从而导致原癌基因和肿瘤抑制因子异常,进而诱导胆管癌的发生发展.最近的研究表明一系列涉及细胞周期调控、细胞信号通路以及核染色体动力学高复发的基因突变可能在胆管癌发生中起到关键性的作用.本文主要介绍胆管癌中潜在关键基因改变与功能,以及在胆管癌的发生、发展中的作用及展望. Objective Cholangiocarcinoma (CCA) is a malignant tumour of bile duct epithelial cells with dismal prognosis and rising incidence.Recent research show that the major contributing factor of cholangiocarcinogenesis is likely through accumulation of serial genetic and epigenetic alterations resulting in aberration of oncogenes and tumour suppressors.Recent studies making use of advances in high-throughput genomics have revealed the genetic landscape of CCA, greatly increasing our understanding of its underlying biology.A series of highly recurrent mutations in genes which are known to be involved in cell cycle control, cell signaling pathways and chromatin dynamics, have led to investigations of their roles, through molecular to mouse modelling studies, in cholangiocarcinogenesis.This review focuses on the landscape genetic alterations in CCA and its functional relevance to the formation and progression of CCA, their roles in the development and progression of cholangiocarcinoma.
作者 谢昱 秦仁义
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2015年第11期2625-2628,共4页 Chinese Journal of Experimental Surgery
关键词 胆管癌 基因突变 Cholangiocarcinoma Gene mutation
  • 相关文献

参考文献35

  • 1Zhou Y,Zhao Y, Li B, et al. Hepatitis viruses infection and risk of in- trahepatic cholangiocarcinoma: evidence from a meta-analysis [ J ]. BMC Cancer,2012,12:289.
  • 2Rizvi S,Gores GJ. Pathogenesis,diagnosis,and management of cholangio- careinoma[ J ]. Gastroenterolo, 2013,145 ( 6 ) : 1215 -1229.
  • 3Sekiya S, Suzuki A. lntrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes [ J]. J Clin Invest, 2012, 122(11 ) :3914-3918.
  • 4Fan B, Malato Y, Calvisi DF, et al. Cholangiocarcinomas can originate from hepatocytes in mice [ J ]. J Clin Invest, 2012, 122 ( 8 ) : 2911 - 2915.
  • 5Saha SK, Parachoniak CA, Ghanta KS, et al. Mutant IDH inhibits HNF-4alpha to hlock hepatocyte differentiation and promnte bifim'y cancer[J]. Nature,2014,513 (7516) :110-114.
  • 6Pinlaor S,Hiraku Y, Ma N, et al. Mechanism of NO-mediated oxida- tive and nitrative DNA damage in hamsters infected with Opisthorehis viverrini:a model of inflammation-mediated carcinogenesis [ J ]. Nitric Oxide,2004,11 ( 2 ) : 175-183.
  • 7Pinlaor S, Ma N, Hiraku Y, et al. Repeated infection with Opisthorchis vivelrini induces accumulation of 8-nitroguanine and 8-oxo-7,8-di- hydro-2' -deoxyguanine in the bile duct of hamsters via inducible ni- tric oxide synthase [ J]. Carcinogenesis ,2004,25 ( 8 ) : 1535-1542.
  • 8Xiaofang L, Kun T, Shaoping Y, et al. Correlation between promoter methylation of pl 4 ( ARF), TMSI/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma[ J ]. World J Surg Onco1,2012, 10:5.
  • 9Sandhu DS,Shire AM, Roberts LR. Epigenetic DNA hypermethylation in cholangiocarcinoma: potential roles in pathogenesis, diagnosis and identification of treatment targets [ J ]. Liver Int,2008,28 ( 1 ) : 12-27.
  • 10Isomoto H, Mort JL, Kobayashi S, et al. Sustained IL-6/STAT-3 signa- ling in cholangiocarcinoma eells due to SOCS-3 epigenetie silencing [ J ], Gastroenterology ,2007,132 ( 1 ) :384-396.

同被引文献22

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部